⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Immunosenescence
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-14 — Immunosenescence and vaccine adjuvants in older adults: from immune decline to signal reconstitution strategies.: [expert-opinion] Review, no new primary data: organizes vaccine-adjuvant strategies for older adults into signal amplification, signal reconstitution, and functional bypass, proposing that compensating for age-associated immune-signaling deficits addresses limitations of antigen optimization alone without newly demonstrating comparative clinical efficacy or reversal of immune aging. [expert-opinion] (novelty: 3)
- 2026-11-14 — Beyond Hematopoiesis: How Immune Are Hematopoietic Stem Cells?: [expert-opinion] Review, no new primary data: positions inflammatory sensing and durable epigenetic memory in hematopoietic stem cells as upstream contributors to myeloid-biased immune output and clonal selection under chronic activation, distinguishing potentially adaptive trained immunity from stem-cell stress without demonstrating that modifying these programs restores immune protection in older humans. [expert-opinion] (novelty: 3)
- 2026-11-14 — RHOA-ROCK hyperactivation is associated with impaired migratory persistence and an effector-associated phenotype in aged CD8T cells.: [mechanism-plausible] Preclinical CD8+ T-cell study associates age-related RHOA–ROCK hyperactivation with reduced migratory persistence, impaired activation-induced clustering, and an effector-associated phenotype rather than memory differentiation, with in vitro reversibility using ROCK inhibitors but no demonstrated restoration of immune protection in humans. [mechanism-plausible] (novelty: 3)
- 2026-11-12 — The DNA Damage Response Induces PD-L1 Expression and Immune Evasion in Senescent Cells: [mechanism-plausible] News report, with experimental models unspecified in the supplied summary, attributes senescent-cell persistence to DNA-damage-response-induced PD-L1 on target cells, distinguishing target-mediated immune inhibition from intrinsic immune-cell aging without demonstrating that checkpoint blockade rejuvenates aged immunity or improves human aging outcomes. [mechanism-plausible] (novelty: 3)
- 2026-11-01 — Immunophenotypic Profiles of General Chinese Population during Natural Aging.: [human-observational] CyTOF profiling of 50 immune subsets in 605 healthy Chinese individuals identified age-associated immune-cell shifts and supported an immune-age metric associated with lifestyle and physiological markers, without establishing causal drivers, longitudinal immune decline, or benefit from changing the score. [human-observational] (novelty: 3)
- 2026-11-01 — Inflammaging as a Dynamic Process in Ageing: Context, Regulation and Functional Consequences.: [expert-opinion] Review, no new primary data: integrates impaired immune surveillance and senescent-cell immune escape into proposed transitions from compensatory to maladaptive and self-sustaining inflammation, without validating these states or showing that restoring immune clearance reverses inflammaging in humans. [expert-opinion] (novelty: 3)
- 2026-11-12 — Granzyme K is a driver of age-related tissue remodeling and functional decline independently of age-associated immune dysfunction.: [animal-model] Granzyme K knockout mice showed reduced age-related kidney and liver fibrosis and preserved organ function without reversing the measured hallmarks of T-cell aging, demonstrating that these tissue outcomes can be uncoupled from classical immunosenescence in this model, with human relevance unestablished. [animal-model] (novelty: 4)
- 2026-11-09 — PHB2 connects mitochondrial membrane remodeling to selective autophagy.: [expert-opinion] Review synthesis proposes PHB2-linked mitophagy and xenophagy as a bridge between mitochondrial quality control and cell-autonomous antibacterial defense; the inference that age-related mitophagy deficits impair this defense remains a mechanism-plausible hypothesis, not a demonstrated human immune-aging mechanism. [expert-opinion] (novelty: 3)
- 2026-11-03 — Senescent CD8 T effector memory cells are functionally impaired, enriched in aging and disease, and a barrier to immunotherapy.: Human single-cell profiling associates senescent CD8 effector-memory T-cell enrichment with aging and disease [human-observational], while preclinical functional assays report failed killing of senescent stromal cells and dominant inhibition of checkpoint-blockade responses [mechanism-plausible], without establishing clinical treatment resistance or benefit from targeting this subset. [mechanism-plausible] (novelty: 3)
- 2026-06-01 — Handgrip strength and risk of common infections and sepsis: Two prospective cohorts with proteomic mediation analysis.: Two prospective human cohorts linked lower handgrip strength to higher subsequent risk of common infections and sepsis after covariate adjustment, with proteomic mediation analysis implicating GDF15 and PLAUR as partial statistical mediators; this human-observational evidence does not establish immunosenescence as the mechanism or show that increasing strength prevents infection. [human-observational] (novelty: 3)
- 2026-10-10 — Bone marrow adipose tissue in cardiometabolic disease: marrow niche remodeling, inflammatory hematopoiesis, and vascular pathology.: 2026 BMAT review positions marrow adipocyte expansion as a niche remodeling event that may skew hematopoiesis toward inflammatory myeloid output, adding a marrow-microenvironment arm to the roster of upstream drivers of immune aging — synthesis only, no primary immune-cell data. [expert-opinion] (novelty: 3)
- 2026-10-09 — Decoding the immune regulation of ovarian aging: mechanisms and therapeutic strategies.: 2026 ovarian-aging review positions systemic immunosenescence (naïve T-cell depletion, cytotoxic/NK decline, myeloid skew) as co-driver of ovarian follicular loss alongside ovarian-microenvironment immune remodeling, adding the ovary as a disease-anchored readout of age-related immune dysfunction — synthesis, no new immune-cell data. [expert-opinion] (novelty: 3)
- 2026-10-10 — THE AGING PURINOME: A PURINERGIC FRAMEWORK LINKING THE HALLMARKS OF AGING TO INFLAMMAGING.: 2026 Aging Purinome review positions age-related shifts in purinergic receptor expression and ectonucleotidase (CD39/CD73) activity on immune cells as a modulator of myeloid/lymphoid aging phenotypes, adding a purinergic signaling arm to the roster of upstream drivers of immune-cell dysfunction — synthesis only, no new immune-cell data. [expert-opinion] (novelty: 3)
- 2026-09-28 — Uncertainty redefines biological age: UK Biobank observational study (>450k, external replication) finds Biological Age Uncertainty (BAU) — predicted-age distribution width across multi-omic/organ models — independently predicts mortality and healthspan loss, consistent with immune-compartment incoherence contributing to aging risk beyond mean immune-age acceleration (association only, not immune-cell phenotyping). [human-observational] (novelty: 4)
- 2026-10-01 — Precision Microbiota Interventions for Senoreduction Trial: Randomized double-blind crossover trial protocol testing two GRAS microbiota-targeted interventions on immune-senescence biomarkers in people with HIV who drink alcohol — extends the microbiota→immunosenescence lever (alongside Polygonatum odoratum RCT) into a canonically accelerated-immune-aging population (HIV + alcohol), protocol only with no readout yet. [human-rct] (novelty: 3)
- 2026-10-06 — Declining Autophagy Impairs Senescent Cell Clearance: News-report restatement of the preclinical finding that age-related autophagy decline impairs macrophage clearance of senescent cells, with pathway activation reducing senescence in aged mice — adds media traction to the autophagy-failure arm of macrophage immunosenescence already logged. [animal-model] (novelty: 3)
- 2026-10-05 — K21 Improves Mitochondrial Function in Macrophages, Extending Life in Nematode Worms: News-tier recap of the K21 study framing drug-induced macrophage metabolic remodeling as a lever on immune-aging phenotype via boosted antimicrobial activity; no new aged mammalian immune endpoint beyond the primary cell + nematode report. [animal-model] (novelty: 3)
- 2026-09-30 — Single‐Cell Mapping Identifies Aging‐Associated Neutrophil Remodeling Across Multiple Organs: Multi-organ single-cell atlas (preclinical) maps age-associated neutrophil remodeling across tissues, adding a tissue-resolved neutrophil arm to the immunosenescence roster alongside the macrophage (Lamtor5), CD8 T-cell (NAD), B-cell, dendritic-cell, and HSC (BIRC6) axes — descriptive atlas, no functional immune-clearance or human readout. [animal-model] (novelty: 3)
- 2026-07-11 — Chronic subdural hematoma as failed resolution at the aged dura-subdural interface: Immune-vascular mechanisms, biomarker interpretation, and therapeutic translation.: 2026 CSDH review positions age-related immune dysfunction (impaired macrophage clearance, dysregulated resolution programs) at the dura-subdural interface as a necessary component of CSDH non-resolution, adding a neurosurgical lesion context to the immunosenescent-clearance-failure roster — synthesis only. [expert-opinion] (novelty: 3)
- 2026-07-28 — Enhancing the anti-ageing capacity of hUC-MSCs via NMN co-treatment in D-galactose-induced ageing mice and cellular senescence models.: D-galactose mouse model: hUC-MSC + NMN co-treatment produced additive anti-immunosenescence benefit over either alone, with Nrf2/HO-1 activation framed as the protective mechanism preserving transplanted MSC function in an aged immune milieu — adds a stem-cell + NAD-precursor combination arm to the roster of candidate immunosenescence-modifying interventions, no human readout. [animal-model] (novelty: 3)
- 2026-09-03 — Aging microenvironment induces CD8T cell exhaustion by suppressing hepatic β-hydroxybutyrylate synthesis.: Preclinical mouse study: aging suppresses hepatic BDH1-dependent β-hydroxybutyrate synthesis, driving CD8 T-cell exhaustion via reduced PRKAR1B β-hydroxybutyrylation and CREM activation; 3HB supplementation restored antiviral, antitumor, and CAR-T responses — adds a hepatic-ketone/CD8-exhaustion axis to the CD8 arm of the immunosenescence roster (alongside the NAD-mtDNA-cGAS CD8 axis) with direct relevance to CAR-T fitness in aged hosts. [animal-model] (novelty: 4)
- 2026-09-03 — IL-21R blockade reduces inflammation and atherosclerosis in LDL receptor deficient mice.: IL-21R blockade in aged Ldlr-/- mice impaired age-associated T follicular helper–B cell dynamics and expanded Tregs, nominating IL-21/IL-21R as a druggable node in the age-skewed adaptive immune compartment driving atherosclerosis — preclinical, with human plaque scRNAseq showing target expression on Tregs. [animal-model] (novelty: 3)
- 2026-10-01 — Associations Between Gut Microbiota and Immune Profiles in Community-Dwelling Older Adults and the Regulatory Role of Polygonatum odoratum.: 2026 90-day double-blind RCT (n=140, community-dwelling adults ≥60) of Polygonatum odoratum (YZG) reported reduction in age-associated TEMRA T-cell subsets alongside fewer respiratory infections, adding a human-trial data point that a dietary/TCM-herb intervention can move a canonical late-differentiated T-cell immunosenescence readout on a 3-month timeframe. [human-rct] (novelty: 3)
- 2026-10-01 — Ghrelin Alleviates Aging-Related Cognitive Impairment by Regulating Autophagy-Related Signaling via the SHBG/JNK1/Beclin1 Axis in Microglia.: Mouse + cell preclinical study with human association data: ghrelin counters microglial senescence via SHBG/JNK1/Beclin1 autophagy induction, adding a hormone-sensitive microglial arm (alongside NR, Lamtor5, C3a–C3AR1, TIMP2) to the CNS-resident myeloid immunosenescence roster. [animal-model] (novelty: 3)
- 2026-10-06 — Sex-stratified immune patterns across the canine lifespan and short-term responses to geroprotective interventions.: Cross-sectional laboratory-Beagle immune-aging characterization with 90-day exploratory geroprotector arms: canine immune aging was heterogeneous and non-linear with sex-stratified cytokine patterns, and short-term rapamycin produced the broadest exploratory cytokine response relative to canagliflozin and dietary restriction — adds a companion-mammal context and a sex-stratification signal to the immunosenescence roster. [animal-model] (novelty: 3)
- 2026-07-16 — Clonal haematopoiesis of indeterminate potential and epigenetic age acceleration: Systematic review and meta-analysis.: 2026 systematic review and meta-analysis (~7,000 adults) links CHIP (especially TET2-mutant and larger clones) to accelerated epigenetic age across four DNAm clocks, strengthening the hematopoietic-clonal-expansion arm of immune aging as a quantifiable contributor to blood-based biological-age readouts — observational, confounded by shared age/exposure drivers of both CHIP and clock acceleration. [human-observational] (novelty: 3)
- 2026-08-22 — Ensemble DNA methylation clock demonstrates Immune-metabolic aging signatures associated with mortality.: 2026 Framingham stacked-ensemble DNAm survival clock finds immune-metabolic CpG features among top mortality-predicting sites, extending the pattern that immunosenescence-related methylation shifts are heavily weighted in mortality-trained second-generation clocks (PhenoAge/GrimAge-class) — observational. [human-observational] (novelty: 3)
- 2026-10-02 — Blood cell composition reveals distinct biological interpretation of DNA methylation age and age acceleration.: 2026 large human observational analysis shows the age-related naïve-to-memory T-cell shift accounts for a majority (~53%) of DNA methylation age signal, quantifying how deeply classical immunosenescent cell-composition drift is embedded in blood-based epigenetic clocks. [human-observational] (novelty: 3)
- 2026-10-05 — Electroacupuncture Targeting the NLRP3 Inflammasome in Senescence‑associated Cognitive Impairment: Mechanistic Synthesis and Meta‑analysis of Clinical Randomized Controlled Trials.: 2026 electroacupuncture meta-analysis (9 RCTs, n≈599, MCI/early AD) implicates NLRP3-driven neuroinflammation as the proposed target but does not phenotype microglia or peripheral immune cells; connection to the innate-immune arm of immune aging is mechanistic framing rather than measurement. [mechanism-plausible] (novelty: 3)
- 2025-11-22 — Nicotinamide riboside supplementation restores microglial health and improves cognition in aged male mice.: Aged male mouse NR supplementation study: boosting NAD precursor availability reversed age-associated microglial gene-expression programs toward homeostatic signatures, extending the roster of druggable upstream levers on tissue-resident macrophage immunosenescence (alongside Lamtor5, CMA decline, energy-metabolism rescue) into brain-resident myeloid cells. [animal-model] (novelty: 3)
- 2026-10-05 — Decline of chaperone-mediated autophagy in aging impairs macrophage clearance of senescent cells.: Preclinical cell + aged-mouse study: age-related CMA decline in macrophages impairs their engulfment of senescent cells, adding CMA failure to the roster of upstream drivers of macrophage immunosenescence (alongside Lamtor5–cGAS, NLRP3 rewiring, and macrophage energy-metabolism collapse) with a specific functional readout — failed senescent-cell clearance. [animal-model] (novelty: 4)
- 2026-03-11 — Communication breakdown: senescent cells in interorgan communication of aging.: 2026 opinion review frames immunosenescent clearance failure as a necessary amplifier of senescent-cell-driven interorgan communication, linking SASP propagation and immune-driven inflammaging to the age-related decline in senescent-cell surveillance — synthesis, no new immune-cell data. [expert-opinion] (novelty: 3)
- 2026-05-20 — Single-cell multiomics gene regulatory landscape reveals impaired spermatogonial stem cells and macrophage-driven inflammaging during testicular aging.: Aged-mouse testis single-cell multiomics adds CD206+ CXCL13+ tissue-resident macrophage expansion as a testis-local arm of the macrophage immunosenescence roster, complementing Lamtor5, wound, Kupffer, and endplate macrophage contexts with a reproductive-organ-resident subset. [animal-model] (novelty: 3)
- 2026-10-01 — Inflammaging reshapes the immune ecosystem in IgG4-related dacryoadenitis and sialadenitis.: 2026 IgG4-RD lesional transcriptome finds age-associated cytotoxic/exhaustion program upregulation together with reduced germinal-centre adaptive immunity, adding a human autoimmune lesion context to the immunosenescence roster where lesional T-cell exhaustion and attenuated GC-B-cell programs co-occur — observational human tissue only. [human-observational] (novelty: 3)
- 2026-09-28 — Functional Shift of NLRP3 Inflammasome Activity in Aged Macrophages.: Preclinical study: aged macrophages repurpose NLRP3 inflammasome signaling toward an apoptosis–senescence fate switch, adding a functional-rewiring mechanism (not just secretory decline) to the macrophage arm of immunosenescence alongside the Lamtor5–cGAS and energy-metabolism axes. [mechanism-plausible] (novelty: 3)
- 2026-10-01 — Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice.: scRNA-seq in aged atherosclerotic mice: rapamycin shifted systemic and vascular immune populations toward regulatory T-cell phenotypes while dampening effector T/B responses and reducing senescent-leukocyte signatures — adds a druggable (mTOR-inhibition) lever specifically remodeling the aged adaptive-immune compartment in a cardiovascular-disease context. [animal-model] (novelty: 3)
- 2026-10-01 — Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images.: 2026 ChromAgeNet applies a 3D chromatin-image CNN to murine hematopoietic stem cells (AUROC ~0.77 young vs aged) and demonstrates proof-of-concept drug screening for HSC rejuvenation — upstream of immune-cell output and relevant to the HSC-intrinsic arm of immunosenescence (alongside BIRC6, IGF-1 niche) but not a direct peripheral immune-cell readout. [animal-model] (novelty: 3)
- 2026-10-01 — The Intersection of Immunosenescence, Cellular Senescence, and Type 1 Diabetes: Paving the Way for Future Interventions.: 2026 review proposes a bidirectional loop in type 1 diabetes where premature immunosenescence (reduced naïve T cells, exhausted CD8 populations, autoreactive B-cell expansion) and β-cell senescence/SASP mutually reinforce autoimmunity, adding T1D as a disease-anchored readout of accelerated immune aging alongside HIV and CMV framings — synthesis, no new primary immune-cell data. [expert-opinion] (novelty: 3)
- 2026-09-29 — Autologous cytokine-induced NK cells as candidate cellular senolytics: evidence, obstacles, and the experiments still needed.: 2026 synthesis review of autologous cytokine-induced NK cells as candidate senolytics implicitly inherits the immunosenescence constraint — age-related NK functional decline is the same biology that would blunt an autologous infusion’s clearance capacity, a gap the proposal frames as a required gating experiment rather than resolves. [expert-opinion] (novelty: 3)
- 2026-05-23 — Chronic low-grade hippocampal inflammation blunts exercise-induced neurogenesis and alters the exercise-induced microglia transcriptome in the rat hippocampus.: 2026 adult-rat IL-1β hippocampal inflammation study found paradoxically worsened microglial lipid-droplet accumulation and an altered exercise-induced microglial transcriptome, extending the aged/dysfunctional-microglia phenotype roster to a chronic-cytokine-exposure model where exercise fails to normalize innate-immune state — rat only, not a canonical immunosenescence readout. [animal-model] (novelty: 3)
- 2026-06-19 — Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan.: 2026 framework review nominates age-related narrowing of epigenetic transition windows as an upstream regulatory substrate for immunosenescent phenotypes (impaired repair, loss of resolution, tumor immune escape), framing immune-cell dysfunction as collapsed state-switching capacity rather than terminal exhaustion alone — synthesis, no new immune-cell data. [expert-opinion] (novelty: 3)
- 2026-07-19 — The circulating senosome: Blood as the therapeutic interface of aging.: 2026 ‘circulating senosome’ review includes autoantibodies and immune-derived mediators within the composite blood-borne aging network, linking immune-compartment aging outputs to a shared systemic therapeutic interface alongside SASP, EVs, and microbial signals; synthesis, no new immune-cell data. [mechanism-plausible] (novelty: 3)
- 2026-07-28 — Is amyloid beta peptide a driver of inflammaging?: 2026 Aβ-inflammaging review invokes cell-type-specific microglial and myeloid responses to amyloid beta as a CNS innate-immune arm of aging, adding Aβ-sensing microglia to the roster of immune-cell phenotypes shaped by aging biology — synthesis only, no new immune-cell data. [expert-opinion] (novelty: 3)
- 2026-09-30 — Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy.: 2026 integrative review reframes lifelong EBV persistence as a functional stress test of aging immune surveillance — age-related loss of EBV-specific CD8 containment, NK function, and tissue immune ecology maps onto reactivation, chronic active EBV disease, and EBV-associated lymphoproliferation/malignancy, adding chronic herpesvirus containment failure as a disease-anchored readout of immunosenescence beyond the existing CMV-adjacent framing; synthesis, no new primary data. [expert-opinion] (novelty: 3)
- 2026-10-01 — Thymic Involution and Function in People With HIV and General Population Controls: A Cross-Sectional Analysis From Two Danish Cohort Studies.: 2026 Danish two-cohort cross-sectional study links higher CT-graded thymus mass to higher sjTREC output, more naïve T cells, and fewer senescent T cells in both treated PWH and general-population controls — human observational evidence tying a radiographic thymic-involution readout directly to peripheral T-cell-compartment immunosenescence markers, with the counterintuitive twist that long-term-treated PWH showed less involution than matched controls. [human-observational] (novelty: 3)
- 2026-08-12 — Clonal hematopoiesis of undetermined potential as an emerging determinant of inflammageing, and age-related diseases: Potential role as biomarker and target.: 2026 CHIP review positions clonal hematopoiesis as a hematopoietic-compartment contributor to age-related immune dysregulation and inflammatory tone, framing CHIP as a potential biomarker/target that intersects with myeloid-biased immunosenescence — narrative synthesis, no new immune-cell data. [expert-opinion] (novelty: 3)
- 2026-09-29 — Infectious diseases and sarcopenia-related phenotypes: A phenome-wide Mendelian randomization study with exploratory proteomic analysis.: 2026 MR-PheWAS of infectious-disease liability against sarcopenia phenotypes: tonsillitis, TB sequelae, and postzoster neuralgia reach FDR significance for appendicular lean mass but no infections survive for grip strength — indirect genetic evidence that specific chronic/latent infection exposures feed muscle-mass loss, consistent with but not demonstrating an immunosenescent-clearance-failure mechanism. [human-observational] (novelty: 3)
- 2025-12-05 — The immuno-neurological axis: association between autoimmune diseases and dementia risk.: 2026 Korean national cohort (~8.7M person-years): autoimmune diseases carried a ~32% higher dementia risk with subtype-specific HRs, offering population-scale human evidence consistent with age-related tolerance failure (ABC/DN2-type autoreactivity, immunosurveillance decline) translating into downstream CNS risk — association only, no immune-cell phenotyping. [human-observational] (novelty: 3)
- 2026-01-25 — Targeted delivery of senolytic drugs using macrophage membrane-camouflaged magnetic nanoparticles inhibits endplate sclerosis.: 2026 LSI-mouse study: targeted ABT-263 delivery via macrophage-membrane-coated magnetic nanoparticles selectively cleared senescent-like macrophages in degenerating endplates, adding endplate-resident macrophages to the tissue-specific macrophage immunosenescence roster (alongside Lamtor5, wound, and Kupffer-cell contexts) with a biomimetic homotypic-targeting delivery angle. [animal-model] (novelty: 3)
- 2026-09-18 — Thymus Grafts Grow in Mouse Spleens, Restoring Immunity: News coverage of a mouse study reporting that thymic tissue grafted into the spleen grew ectopically, reversed age-related thymic involution, and restored antiviral and antitumor immune responses — nominates ectopic thymic regeneration as a candidate lever on the T-cell arm of immunosenescence, upstream of the peripheral macrophage/CD8/B-cell nodes already logged; preclinical only, news-tier report. [animal-model] (novelty: 3)
- 2026-09-25 — A Unified Cause for Loss of Type 1 Dendritic Cell Function in Aging, Cancer, and Chronic Infection: 2026 secondary coverage of a paper proposing a unified upstream cause for type 1 conventional dendritic cell (cDC1) functional loss across aging, cancer, and chronic infection, framing impaired cytotoxic T-cell priming as a convergent downstream consequence — adds a cDC1 arm to the immunosenescence roster alongside macrophage (Lamtor5), CD8 T-cell (NAD), B-cell, and HSC (BIRC6) axes; news-tier report, no primary data reviewed here. [mechanism-plausible] (novelty: 3)
- 2026-09-23 — Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice: 2026 aged atherosclerotic mouse study: therapeutic rapamycin reprogrammed lymphoid immune responses and dampened plaque immune activation, extending mTOR-inhibition’s reach into the aged adaptive-immune compartment specifically within an atherosclerotic context. [animal-model] (novelty: 3)
- 2026-09-12 — Age-related IGF-1 decline permits a redox-sensitive transcriptional shift that directs hematopoiesis toward a CCR2myeloid fate.: 2026 preclinical study proposes age-related bone-marrow IGF-1 decline as an upstream trigger of an oxidative-stress/NF-κB/IRF8 transcriptional cascade that redirects HSCs to a CCR2+ myeloid trajectory, adding a stromal-niche IGF-1 arm to the roster of upstream drivers of myeloid-biased immunosenescence alongside BIRC6 (HSC-intrinsic), Lamtor5 (macrophage), and NAD (CD8 T-cell) axes. [animal-model] (novelty: 3)
- 2026-09-18 — Age-dependent genetic effects contribute to immunosenescence in Drosophila melanogaster.: 2026 multi-genotype Drosophila study: age-dependent genetic effects explain most variation in age-related bacterial-clearance decline, with largely non-overlapping candidate genes and pathways governing immune performance in young vs old flies — adds an invertebrate genetic-architecture argument that immunosenescence is not simply attenuation of youthful immunity but a distinct age-specific program. [animal-model] (novelty: 3)
- 2026-09-18 — Frailty of older patients is not reflected in the melanoma tumor microenvironment and treatment response to immune checkpoint blockade therapy.: 2026 imaging mass cytometry study (n=23 older melanoma patients): clinical frailty was not broadly reflected in pretreatment tumor immune microenvironment composition, and frail vs non-frail patients had comparable overall survival and ICB clinical benefit — a small-cohort tissue-level dissociation between systemic immunosenescence/frailty phenotype and tumor-local immune competence. [human-observational] (novelty: 3)
- 2026-09-22 — Acute viral respiratory infections are not associated with an increased IMMune Age indeX (IMMAX) four weeks after infection: a prospective observational cohort study.: 2026 prospective observational cohort: mild-to-moderate community-acquired viral respiratory infections followed by full recovery did not elevate the flow-cytometry-based IMMAX immune-age score at four weeks post-infection, though acute SARS-CoV-2 produced distinct transient shifts in systemic immune-cell proportions — a negative finding against the intuition that routine viral illness durably ages the immune system on this surrogate. [human-observational] (novelty: 3)
- 2026-09-23 — Targeting BIRC6 rejuvenates hematopoietic stem cell aging and immunosenescence.: 2026 mouse study: BIRC6 inhibition via antibody-conjugated LNP-ASOs reverses immunosenescence downstream of a BM Treg–cAMP–PKA–CREB–BIRC6 axis by clearing apoptosis-resistant aged HSCs, adding an HSC-intrinsic upstream node to the immunosenescence roster alongside Lamtor5 (macrophage), NAD (CD8 T-cell), and B-cell arms. [animal-model] (novelty: 4)
- 2026-09-19 — 3D-Printed and Biofabricated Scaffolds for Osteoporotic Bone Defect Repair: Mechanical Adaptation, Redox Control, Senescence Modulation and Osteoimmunomodulation.: 2026 scaffold review frames osteoimmunomodulation (macrophage polarization in aged bone) as a distinct scaffold-design axis for osteoporotic defect repair, tying local immune-aging phenotypes at the bone–implant interface to healing failure — preclinical multifunctional scaffold evidence only. [expert-opinion] (novelty: 3)
- 2026-09-25 — Longitudinal proteomic organ-specific aging in heart failure.: 2026 longitudinal HF proteomic-organ-age study: immune organ age gap independently predicts adverse cardiac outcomes beyond NT-proBNP/troponin T, providing longitudinal human evidence that a proteomic ‘immune age’ readout carries prognostic weight in a cardiac disease context. [human-observational] (novelty: 4)
- 2026-09-15 — Common and distinct plasma proteomic signature of aerobic and motor physical activity interventions and their link to episodic memory.: 2026 exploratory proteomic RCT sub-study (n=34): aerobic exercise produces a distinct 33-protein immune/vascular plasma signature beyond the modality-shared inflammatory set, nominating aerobic-specific remodeling of circulating immune proteins as a candidate immunosenescence-modifying axis — small-n, hypothesis-generating. [human-rct] (novelty: 3)
- 2026-09-16 — Sex-specific biological aging clocks across organs and omics.: 2026 sex-specific organ-aging clocks study reports sex-divergent proteomic-network aging in immune-relevant organ systems among the 15 profiled, adding a sex-stratification argument to immune-aging biomarker construction that pooled immunosenescence clocks obscure — descriptive multi-omics only. [human-observational] (novelty: 4)
- 2026-09-16 — Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis.: Human observational CH profiling adds a mutation-stratified layer to hematopoietic immune-aging: DNMT3A clones carry an RTE-driven inflammatory/senescence signature while TET2 clones tilt toward OXPHOS/mTORC1, refining which CH subtypes plausibly contribute to inflammation-linked immune dysfunction. [human-observational] (novelty: 3)
- 2026-09-17 — Drug-induced metabolic remodeling promotes antimicrobial activity in macrophages and extends longevity in vivo.: K21 study reports macrophage repertoire shifts and boosted antimicrobial activity via mitochondrial remodeling, framing metabolic reprogramming of macrophages as a lever on the immune-aging phenotype — preclinical only, no aged mammalian immune endpoint. [animal-model] (novelty: 3)
- 2026-09-14 — MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.: Gaucher disease mouse + iPSC study: MA-5 reversed pathological microglial states driven by mtDNA–cGAS–STING/NLRP3 signaling, adding disease-associated microglia to the roster of aged/dysfunctional innate-immune phenotypes reversible by upstream mitochondrial-cristae repair rather than direct immune-cell targeting. [animal-model] (novelty: 3)
- 2026-09-25 — The Interplay of Metabolic Dysfunction, Neuroinflammation, and Mitochondrial Dysfunction in Balance Impairment: Insights from Type 2 Diabetes Mellitus and Alzheimer’s Disease.: 2026 T2DM/Alzheimer’s balance-impairment review invokes NLRP3-inflammasome-primed microglial activation (an immune-aging-adjacent innate program) as part of a shared metabolic–neuroinflammatory–mitochondrial cycle, but does not add new immune-cell mechanistic data — synthesis only. [expert-opinion] (novelty: 3)
- 2026-09-17 — Stress and cancer from an integrative psychoneuroimmunology perspective: Neurobiological mechanisms and clinical implications.: 2026 stress–cancer psychoneuroimmunology review consolidates neuroendocrine (glucocorticoid + β-adrenergic) impairment of NK and cytotoxic T-cell antitumor immunosurveillance as a stress-driven contributor to immune-aging phenotypes, adding a psychosocial-stress arm to the immunosenescence roster alongside intrinsic (Lamtor5, NAD, B-cell) axes; narrative synthesis, no new immune-cell data. [expert-opinion] (novelty: 3)
- 2026-09-23 — Engineered Extracellular Vesicle Revitalizing Macrophage Energy Metabolism for Aged Wound Repair.: 2026 preclinical study: engineered 4-Octyl itaconate extracellular vesicles reverse aged/diabetic wound macrophage senescence by restoring ASS1–arginine–OXPHOS metabolism, adding a wound-macrophage arm and an immunometabolite-EV delivery modality to the macrophage-immunosenescence roster. [animal-model] (novelty: 3)
- 2026-09-21 — Senescent Cell Heterogeneity: Tissue-Dependent Signatures and Age Dynamics Revealed by Human scRNA-Seq Data.: 2026 human multi-tissue scRNA-seq atlas finds senescent cells across skin, lung, intestine, kidney, and heart upregulate antigen-presentation programs alongside classical SASP, connecting the immune-clearance failure narrative of immunosenescence to a cell-intrinsic antigen-presentation phenotype on senescent cells themselves — descriptive human observational data, no functional immune-clearance assays. [human-observational] (novelty: 3)
- 2026-09-15 — The Oral Microbiome-Inflammaging Axis in Elderly Periodontitis: Emerging Immunopathogenic and Systemic Mechanisms.: 2026 review positions age-related decline in mucosal and systemic immune surveillance as a co-driver of periodontitis chronicity in older adults, linking immunosenescent myeloid/lymphoid responses to failure to resolve oral dysbiosis and to downstream systemic inflammatory spillover — synthesis, no new immune-cell data. [expert-opinion] (novelty: 3)
- 2026-09-16 — Immunosenescence and immune-organ axis dysfunction: Potential of algal bioactives and nutritional interventions for healthy ageing.: 2026 conceptual review frames an ‘immune-organ axis’ and proposes algal bioactives plus nutritional interventions as candidate levers against immunosenescence via autophagy induction, inflammation resolution, and cellular repair — integrative synthesis, no primary data. [expert-opinion] (novelty: 3)
- 2026-09-21 — A two-step model of age-associated autoreactivity: B cell-intrinsic aging meets inflammaging.: 2026 review adds B-cell-intrinsic tolerance failure (central and peripheral) plus inflammaging-driven expansion of ABC/DN2 subsets to the immunosenescence roster, complementing prior macrophage (Lamtor5), CD8 T-cell (NAD), and dendritic-cell axes with a B-cell arm explicitly linked to autoimmunity — conceptual synthesis, no new primary data. [expert-opinion] (novelty: 3)
- 2026-09-21 — Why Some People Live Past 100: The Role of the Immune System in Centenarians, Semi-Supercentenarians and Supercentenarians.: 2026 narrative review of conventional and single-cell immunology in centenarians/semi- and supercentenarians reframes extreme longevity as selective immune remodeling — NK-cell expansion, effector/cytotoxic T-cell enrichment, and better-controlled inflammatory tone — rather than retention of a youthful immune system, positioning centenarian immunity as adaptive accommodation to immunosenescence rather than its absence. [expert-opinion] (novelty: 3)
- 2026-09-26 — Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.: 2026 aging rhesus macaque plasma+CSF proteomics recovers immunosenescence-adjacent signatures conserved with humans, supporting NHPs as a translational model for immune-aging biomarker validation — descriptive only, no functional immune-cell assays. [animal-model] (novelty: 3)
- 2026-09-11 — Dendritic Cell Antigen Presentation Enables T Cells to Enter the Brain and Contribute to Tau Pathology: News-reported preclinical work nominates dendritic-cell antigen presentation as a gate for peripheral T-cell entry into the aged brain that worsens tau pathology, extending the immunosenescence roster beyond innate/macrophage axes to a dendritic-cell → T-cell arm relevant to neurodegeneration. [mechanism-plausible] (novelty: 3)
- 2026-09-09 — Canonical complement C3a-C3AR1 signalling in ageing and age-related disease: Cellular mechanisms, tissue-specific effects and translational challenges.: 2026 C3a–C3AR1 review frames chronic C3a receptor engagement as a driver of aged macrophage and microglial phenotype shifts (immunometabolic reprogramming toward a pro-inflammatory state), adding complement-anaphylatoxin signalling to the roster of upstream nodes shaping myeloid immunosenescence — synthesis, no new immune-cell data. [expert-opinion] (novelty: 3)
- 2026-09-12 — Influenza vaccination as a modulator of inflammaging: trained tolerance as a mechanistic lens on heterologous effects in age-related diseases.: 2026 review positions annual influenza vaccination as an inducer of durable myeloid epigenetic reprogramming (trained tolerance) that partially counters the age-skewed inflammatory myeloid phenotype, extending immunosenescence discussion beyond adaptive-compartment decline to modifiable innate memory — synthesis, not primary evidence. [expert-opinion] (novelty: 3)
- 2026-09-10 — Blocking PD-L2 prevents senescent cell accumulation and age-related dysfunction.: 2026 mouse study: senescent cells evade immune surveillance by upregulating the PD-L2 checkpoint ligand; blocking PD-L2 (antibody or knockout) restored immune clearance of senescent cells and rescued insulin sensitivity and grip strength — extends immunosenescence biology into a checkpoint-blockade framework where age-related failed clearance is partly a druggable inhibitory-ligand problem. [animal-model] (novelty: 4)
- 2026-07-17 — Cellular Senescence and COVID-19 Long-Hauler Syndrome: cross-connection with cellular-senescence: Long COVID rationale invokes both a virally amplified senescent-cell/SASP burden and immunosenescent failure to clear infected/senescent cells as convergent substrates for post-viral chronicity. (novelty: 3)
- 2026-08-18 — A Novel Approach Utilizing Organ Specific Age Proteomics: 2026 observational proposal in early-stage breast cancer adjuvant chemotherapy: pairs T-cell p16INK4A (immune-aging readout) with organ-specific plasma proteomic ages pre/post-treatment to test whether immune aging tracks multi-organ biological aging and predicts late toxicities — extends the immunosenescence biomarker literature into an oncology risk-stratification use case, no outcome data yet. [human-observational] (novelty: 3)
- 2026-09-10 — NAD+ Metabolic Reprogramming Drives CD8+ T Cells Senescence and Exacerbates Ulcerative Colitis: Already logged 2026-09-01 — NAD+ metabolic reprogramming triggers mtDNA–cGAS–STING-dependent CD8 T-cell senescence worsening mouse colitis with human severity correlates, adding CD8 T cells (with a specific NAD metabolic upstream) to the immunosenescence roster alongside the macrophage Lamtor5 axis. [animal-model] (novelty: 3)
- 2026-09-01 — NADMetabolic Reprogramming Drives CD8T Cells Senescence and Exacerbates Ulcerative Colitis.: 2026 UC study: NAD metabolic reprogramming induces mtDNA–cGAS–STING-dependent CD8 T-cell senescence that worsens colitis in mice, with human severity and treatment non-response correlations — adds CD8 T cells to the immunosenescence roster alongside the macrophage (Lamtor5) axis, with a specific metabolic upstream (NAD) trigger. [animal-model] (novelty: 3)
- 2026-07-17 — Improving Physical Ability and Cellular Senescence Elimination in HIV: cross-connection with cellular-senescence: Long-term HIV on ART is a canonical accelerated-immunosenescence population; this D+Q trial operationalizes the cellular-senescence → immunosenescence link as a testable human endpoint (physical function in a chronically inflamed, immune-aged cohort). (novelty: 3)
- 2026-08-26 — Insights into longevity and virus-driven adaptation from Myotis bat genomes: 2025 Nature news on Myotis bat genomes flags viral selective pressure as a shaper of bat immune-gene repertoires, offering comparative-biology context for why long-lived bats may resist immunosenescence — no direct mammalian aging mechanism established. [animal-model] (novelty: 3)
- 2025-11-22 — Exploring the role of β2-microglobulin in the relationship between physical activity and DNAm-predicted PhenoAge: Evidence from a population-based and mice single-cell RNA-sequencing study.: 2026 mediation study positions circulating β2-microglobulin — a canonical MHC-I-derived immunosenescence marker — as accounting for ~38% of the physical activity → DNAm-PhenoAge link in a U.S. cohort, extending β2M’s aging relevance from prior heterochronic parabiosis biology into human epidemiological mediation. [human-observational] (novelty: 3)
- 2026-03-17 — Gut Microbiota Resilience and Environmental Stressors: A Hidden Key to Lifespan Optimization?: 2026 gut microbiota resilience review argues that eroded microbial resilience under environmental stressors feeds age-related immune dysregulation via microbiota–immune crosstalk, invoking immunosenescence as a downstream consequence rather than adding immune-cell-level mechanistic data — synthesis only. [expert-opinion] (novelty: 3)
- 2026-04-13 — The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.: 2026 GLAM-framework review implicates immune dysregulation and inflammaging within the sarcopenia-anchored multi-organ axis but does not add new immunosenescence-specific mechanistic data — synthesis only. [expert-opinion] (novelty: 3)
- 2026-06-12 — Chimeric Antigen Receptor T Cells as Living Therapeutics Targeting Senescence and Age-Related Diseases.: cross-connection with cellular-senescence: CAR T senolytic pitch depends on engineered T-cell fitness in aged hosts, colliding with immunosenescence-driven T-cell exhaustion — the same recipient biology that limits oncology CAR T durability is a gap the aging-CAR T narrative largely elides. (novelty: 3)
- 2026-07-16 — Age-associated decline of Lamtor5 drives immunosenescence and systemic aging via cGAS-mediated paracrine inflammation.: 2026 mouse study: Lamtor5 decline in aged macrophages is sufficient to induce macrophage immunosenescence via cGAS accumulation and paracrine cGAS–STING signaling; young-macrophage transplant, macrophage-targeted cGAS blockade, or senolytic treatment rescue peripheral tissue aging — first named upstream node for macrophage immunosenescence in this vault. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Immunosenescence and vaccine adjuvants in older adults: from immune decline to signal reconstitution strategies.
14-nov-2026
novelty 3
per-area 3
strengthens
Beyond Hematopoiesis: How Immune Are Hematopoietic Stem Cells?
14-nov-2026
novelty 3
per-area 3
strengthens
RHOA-ROCK hyperactivation is associated with impaired migratory persistence and an effector-associated phenotype in aged CD8T cells.
14-nov-2026
novelty 3
per-area 3
strengthens
The M1/M2 View of Macrophage Polarization is a Considerable Simplification
13-nov-2026
novelty 2
per-area 2
mentions
Premature immune aging in obesity: a testable framework linking immunosenescence, metaflammation, and multiorgan dysfunction.
12-nov-2026
novelty 2
per-area 2
weakens
The DNA Damage Response Induces PD-L1 Expression and Immune Evasion in Senescent Cells
12-nov-2026
novelty 3
per-area 3
strengthens
Epigenetic regulation of the complement system in age-related chronic inflammation: mechanisms and therapeutic prospects.
12-nov-2026
novelty 2
per-area 2
strengthens
Granzyme K is a driver of age-related tissue remodeling and functional decline independently of age-associated immune dysfunction.
12-nov-2026
novelty 4
per-area 4
strengthens
Systems Investigation of Vaccine Responses in Aging and Frailty
10-nov-2026
novelty 2
per-area 2
mentions
Ultrasound for Healthy Aging
09-nov-2026
novelty 3
per-area 2
mentions
PHB2 connects mitochondrial membrane remodeling to selective autophagy.
09-nov-2026
novelty 3
per-area 3
strengthens
Senescent CD8 T effector memory cells are functionally impaired, enriched in aging and disease, and a barrier to immunotherapy.
03-nov-2026
novelty 3
per-area 3
strengthens
Immunophenotypic Profiles of General Chinese Population during Natural Aging.
01-nov-2026
novelty 3
per-area 3
strengthens
Inflammaging as a Dynamic Process in Ageing: Context, Regulation and Functional Consequences.
01-nov-2026
novelty 3
per-area 3
strengthens
Glucose-Lowering Therapies in Type 2 Diabetes-Associated Sarcopenia: Mechanisms, Clinical Evidence and a Muscle-Centred Framework.
17-oct-2026
novelty 3
per-area 1
mentions
Bone marrow adipose tissue in cardiometabolic disease: marrow niche remodeling, inflammatory hematopoiesis, and vascular pathology.
10-oct-2026
novelty 3
per-area 3
strengthens
THE AGING PURINOME: A PURINERGIC FRAMEWORK LINKING THE HALLMARKS OF AGING TO INFLAMMAGING.
10-oct-2026
novelty 3
per-area 3
strengthens
Decoding the immune regulation of ovarian aging: mechanisms and therapeutic strategies.
09-oct-2026
novelty 3
per-area 3
strengthens
Effects of kinetin on thymic lymphocyte proliferation, mitochondrial membrane potential, and apoptosis-regulatory gene expression in D-galactose-induced aging rats.
08-oct-2026
novelty 2
per-area 2
strengthens
Declining Autophagy Impairs Senescent Cell Clearance
06-oct-2026
novelty 3
per-area 3
strengthens
Anti-CXCR3 Therapy Reduces Harmful Immune Cell Infiltration into the Brain
06-oct-2026
novelty 2
per-area 2
strengthens
Sex-stratified immune patterns across the canine lifespan and short-term responses to geroprotective interventions.
06-oct-2026
novelty 3
per-area 3
strengthens
Shorter Leukocyte telomere length as a marker of biological aging in relapsing-remitting multiple sclerosis.
06-oct-2026
novelty 2
per-area 2
strengthens
Circulating TNF-α, CCL2 and IL-6 are associated with blood-based epigenetic age and targeted CpG methylation signatures in aging mice.
06-oct-2026
novelty 2
per-area 2
mentions
K21 Improves Mitochondrial Function in Macrophages, Extending Life in Nematode Worms
05-oct-2026
novelty 3
per-area 3
strengthens
An Aging Clock Based on Images of Hematopoietic Stem Cell Nuclei
05-oct-2026
novelty 3
per-area 2
mentions
In vitro generation of regulatory T cells: A challenging tool for studying immune aging in humans.
05-oct-2026
novelty 2
per-area 2
strengthens
Electroacupuncture Targeting the NLRP3 Inflammasome in Senescence‑associated Cognitive Impairment: Mechanistic Synthesis and Meta‑analysis of Clinical Randomized Controlled Trials.
05-oct-2026
novelty 3
per-area 3
strengthens
Decline of chaperone-mediated autophagy in aging impairs macrophage clearance of senescent cells.
05-oct-2026
novelty 4
per-area 4
strengthens
Arginine methylation in immunoregulation: Mechanisms and therapeutic targeting.
05-oct-2026
novelty 2
per-area 2
strengthens
Fight Aging! Newsletter, October 5th 2026
04-oct-2026
novelty 2
per-area 3
mentions
Immunosenescence in tumor progression: from synergistic mechanisms to therapeutic strategies.
03-oct-2026
novelty 2
per-area 3
strengthens
Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West Africa
02-oct-2026
novelty 3
per-area 2
mentions
The Dortmund Vital Study: Impact of Biological and Lifestyle Factors on Cognitive Performace and Work Ability
02-oct-2026
novelty 2
per-area 2
mentions
Blood cell composition reveals distinct biological interpretation of DNA methylation age and age acceleration.
02-oct-2026
novelty 3
per-area 3
strengthens
Precision Microbiota Interventions for Senoreduction Trial
01-oct-2026
novelty 3
per-area 3
strengthens
Associations Between Gut Microbiota and Immune Profiles in Community-Dwelling Older Adults and the Regulatory Role of Polygonatum odoratum.
01-oct-2026
novelty 3
per-area 3
strengthens
Ghrelin Alleviates Aging-Related Cognitive Impairment by Regulating Autophagy-Related Signaling via the SHBG/JNK1/Beclin1 Axis in Microglia.
01-oct-2026
novelty 3
per-area 3
strengthens
Intoxication, inflammaging, and injury: my journey through leukocyte biology.
01-oct-2026
novelty 1
per-area 1
mentions
Inflammaging reshapes the immune ecosystem in IgG4-related dacryoadenitis and sialadenitis.
01-oct-2026
novelty 3
per-area 3
strengthens
Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice.
01-oct-2026
novelty 3
per-area 3
strengthens
Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images.
01-oct-2026
novelty 3
per-area 3
strengthens
The Intersection of Immunosenescence, Cellular Senescence, and Type 1 Diabetes: Paving the Way for Future Interventions.
01-oct-2026
novelty 3
per-area 3
strengthens
The Role of EVs in the Aging Hematopoietic System.
01-oct-2026
novelty 2
per-area 2
strengthens
Thymic Involution and Function in People With HIV and General Population Controls: A Cross-Sectional Analysis From Two Danish Cohort Studies.
01-oct-2026
novelty 3
per-area 3
strengthens
Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All-Cause Mortality.
01-oct-2026
novelty 3
per-area 2
strengthens
Extracellular vesicles: Multi-source regulatory mechanisms in hippocampal homeostasis.
01-oct-2026
novelty 2
per-area 2
mentions
Single‐Cell Mapping Identifies Aging‐Associated Neutrophil Remodeling Across Multiple Organs
30-sep-2026
novelty 3
per-area 3
strengthens
From Regenerative to Degenerative Niche: Multicellular Crosstalk and Population Dynamics in Skeletal Muscle Aging
30-sep-2026
novelty 2
per-area 2
mentions
Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy.
30-sep-2026
novelty 3
per-area 3
strengthens